ATARA Biotherapeutics (ATRA) Reports Expansion of T-Cell Immunotherapy Collaboration with Memorial Sloan … – StreetInsider.com
|
ATARA Biotherapeutics (ATRA) Reports Expansion of T-Cell Immunotherapy Collaboration with Memorial Sloan …
StreetInsider.com Atara Biotherapeutics, Inc. (NASDAQ: ATRA) today announced the Company has expanded its collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop the next generation of genetically engineered chimeric antigen receptor T-cell (CAR T … |
